Shares of CVS Health rose 2% Monday on news that investor Glenview Capital Management would meet with top executives to propose improvements for the struggling healthcare giant. While specifics about the hedge fund's proposals were not available,

CVS Health Corp.’s stock rose 2.6% Monday after a report surfaced of a meeting between the health-care company and its major hedge-fund investor, Glenview Capital Management. CVS’s stock rose $1.65 to $63.

Glenview Capital Management — a hedge fund that has been subject of certain media reports that it was pushing CVS Health management to break up the healthcare giant — denies it is “pushing for a break-up.”